The aim was to reflect the needs of customers even more and to put the added value of the products in the foreground. This is now manifested, among other things, in the new brand claim: seeing what matters.

In parallel, the development team has made significant progress in expanding the product range. The prototypes mdknee, which enables precise and comprehensive classification of cartilage damage to the knee, and mdprostate, for automatic segmentation, are drivers for future growth.

Both the new brand appearance and the new prototypes attracted a lot of attention at the 103rd German Congress of Radiology in Wiesbaden. Also at the Italian Congress of Neuroradiology in Rome, the new branding and the latest version of mdbrain, left a very positive impression and set important impulses.

Next, interested parties can experience mediaire at the ECR European Congress of Radiology 2022, July 13-17 in Vienna.